TW
NVO

Traveka Wealth’s Novo Nordisk NVO Stock Holding History

Traveka Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+5,265
New +$226K 0.08% 156
2026
Q1 		– Sell
-5,950
Closed -$303K – 200
2025
Q4 		$303K Sell
5,950
-836
-12% -$42.8K 0.12% 130
2025
Q3 		$377K Sell
6,786
-815
-11% -$47.7K 0.17% 97
2025
Q2 		$525K Sell
7,601
-1,353
-15% -$92K 0.28% 61
2025
Q1 		$622K Buy
8,954
+954
+12% +$78.8K 0.35% 52
2024
Q4 		$688K Sell
8,000
-552
-6% -$59.7K 0.38% 53
2024
Q3 		$1.02M Sell
8,552
-83
-1% -$11.1K 0.52% 38
2024
Q2 		$1.23M Buy
8,635
+732
+9% +$97K 0.6% 33
2024
Q1 		$1.01M Buy
7,903
+536
+7% +$63.8K 0.47% 35
2023
Q4 		$762K Buy
+7,367
New +$729K 0.38% 47

Other funds holding NVO

EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Traveka Wealth's NVO Position: Q2 2026 in Review

Traveka Wealth opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,265 shares worth $252K. The stake represents 0.08% of the portfolio and ranks #156 among its holdings. This is a return to the name: Traveka Wealth previously reported a position in NVO as recently as Q4 2025.

Traveka Wealth first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.23M in Q2 2024. 627 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Traveka Wealth held 5,265 shares of Novo Nordisk worth $252K as of Q2 2026.
  • Novo Nordisk was a new Traveka Wealth position in Q2 2026.
  • Novo Nordisk made up 0.08% of Traveka Wealth's portfolio in Q2 2026, its #156 holding.
  • Traveka Wealth first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Traveka Wealth's Novo Nordisk position peaked at $1.23M in Q2 2024.
  • 627 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.